An interventional study of Adipeau face cream in Atrophy, Hemifacial, Elastosis and Photoaging, sponsored by Adipeau Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.
Sponsored by Adipeau Inc. · Not applicable, Interventional, and Treatment
A Clinical Trial Evaluating Efficacy of a Skin Cream Targeting Dermal Fat in Improving the Skin Elasticity of Healthy Volunteers.
This is a single-arm study with subjects serving as their own controls. The study evaluates a face cream comprised of natural agents with adipogenic and lipolytic activities. The combination of adipogenic and lipolytic impulses is theorized to be more effective in promoting regeneration and healthy cell size in the dermal white adipose tissue than other approaches (e.g., adipogenic + lipogenic or anti-adipogenic + lipolytic). The health of the dermal white adipose tissue is reflected by the strength and elasticity of the skin and the distribution of volume in the face.
828 studies on the registry are indexed under Atrophy; 122 are open to participants now.
This study's enrollment of 35 is close to the median of 34 across 603 interventional studies indexed under Atrophy.
Browse Atrophy studies →This is the only study on the registry with Adipeau Inc. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
-
Exclusion Criteria:
Cosmetic cream
Other: Adipeau face cream
Adipeau face cream contains the natural actives Carthamus Tinctorius (Safflower) Seed Oil and Kaempferia Parviflora Rhizome Extract (Black Ginger).
Change in Skin Elasticity
Elasticity measured by DermaLab Skin Elasticity Meter.
Time frame: Six months and 12 months..
Change in Skin Volume
Increases and decreases measured by Cherry Imaging 3D Scanning System.
Time frame: Six months and 12 Months.
FaceQ skin satisfaction surveys
Satisfaction With Skin, Appraisal of Lower Eyelids, Satisfaction with Cheeks, Adverse Effects
Time frame: Two, Six and 12 Months.
Plan to share: No
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Facial Hemiatrophy